SBIO.L vs. ^GSPC
Compare and contrast key facts about Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and S&P 500 (^GSPC).
SBIO.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Nov 6, 2014.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SBIO.L or ^GSPC.
Correlation
The correlation between SBIO.L and ^GSPC is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SBIO.L vs. ^GSPC - Performance Comparison
Key characteristics
SBIO.L:
0.17
^GSPC:
1.83
SBIO.L:
0.36
^GSPC:
2.47
SBIO.L:
1.04
^GSPC:
1.33
SBIO.L:
0.13
^GSPC:
2.76
SBIO.L:
0.52
^GSPC:
11.27
SBIO.L:
6.16%
^GSPC:
2.08%
SBIO.L:
18.41%
^GSPC:
12.79%
SBIO.L:
-39.44%
^GSPC:
-56.78%
SBIO.L:
-15.80%
^GSPC:
-0.07%
Returns By Period
In the year-to-date period, SBIO.L achieves a 5.14% return, which is significantly higher than ^GSPC's 3.96% return. Over the past 10 years, SBIO.L has underperformed ^GSPC with an annualized return of 2.85%, while ^GSPC has yielded a comparatively higher 11.26% annualized return.
SBIO.L
5.14%
4.75%
-5.86%
3.01%
3.58%
2.85%
^GSPC
3.96%
1.97%
9.03%
22.16%
12.60%
11.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SBIO.L vs. ^GSPC — Risk-Adjusted Performance Rank
SBIO.L
^GSPC
SBIO.L vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
SBIO.L vs. ^GSPC - Drawdown Comparison
The maximum SBIO.L drawdown since its inception was -39.44%, smaller than the maximum ^GSPC drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for SBIO.L and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
SBIO.L vs. ^GSPC - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a higher volatility of 5.32% compared to S&P 500 (^GSPC) at 3.07%. This indicates that SBIO.L's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.